Articles from Inspection Monitor (November 1, 1997)

Title	Author	Type	Words
Back-to-back inspections show site-to-site variability.		Brief Article	607
Blood bank outdoes rules, gets praise instead of 483.		Brief Article	355
First audit of EBI plant leads to warning letter.		Brief Article	838
Five years of audits show ups and downs at Lifecore.		Brief Article	793
INSPECTION LOG.		Brief Article	796
Merck, FDA debate sales prior to NDA supplement.		Brief Article	913
Miscommunication seen marring validation review.		Brief Article	388
More second-guessing seen on product changes : Primarily in biologics, also devices.		Brief Article	621
Notice of inspection fails to help Bartels avoid 483.		Brief Article	714
PML survives 5-year gap in audits with no big slips.		Brief Article	480
Post-approval, field alert audits spare Lederle 483s.		Brief Article	388
Re-formed company cited on GMPs after conviction.			1108